Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00412

Submission Number:
00412
Commenter:
Ashwin Waghray
State:
Arizona
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
Giving both sides of the coin to the same company Harms any self respecting provider as this Company can control the providers payroll to the benefit Of its own bottom line In the same state where one pharmacy closes the other Has a net profit to buy a company worth 88 billion paying its employees the same and sourcing from the same manufacturers This is only possible because of different reimbursement rates For themselves as compared to everyone else . And in th the absence regulation for PBMS Pharmacists are committing suicides